DE60209698D1 - Mikanolid-derivate, ihre herstellung und ihr gebrauch für therapeutische anwendungen - Google Patents

Mikanolid-derivate, ihre herstellung und ihr gebrauch für therapeutische anwendungen

Info

Publication number
DE60209698D1
DE60209698D1 DE60209698T DE60209698T DE60209698D1 DE 60209698 D1 DE60209698 D1 DE 60209698D1 DE 60209698 T DE60209698 T DE 60209698T DE 60209698 T DE60209698 T DE 60209698T DE 60209698 D1 DE60209698 D1 DE 60209698D1
Authority
DE
Germany
Prior art keywords
micanolide
derivatives
preparation
therapeutic applications
therapeutic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60209698T
Other languages
English (en)
Other versions
DE60209698T2 (de
Inventor
Olivier Lavergne
Christophe Lanco
Gregoire Prevost
Poon Teng
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ipsen Pharma SAS
Original Assignee
Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0100397A external-priority patent/FR2819513B1/fr
Application filed by Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS filed Critical Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS
Publication of DE60209698D1 publication Critical patent/DE60209698D1/de
Application granted granted Critical
Publication of DE60209698T2 publication Critical patent/DE60209698T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/12—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains three hetero rings
    • C07D493/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Urology & Nephrology (AREA)
  • Virology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicinal Preparation (AREA)
DE60209698T 2001-01-12 2002-01-11 Mikanolid-derivate, ihre herstellung und ihr gebrauch für therapeutische anwendungen Expired - Lifetime DE60209698T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
FR0100397A FR2819513B1 (fr) 2001-01-12 2001-01-12 Nouveaux derives du mikanolide, leur preparation et leurs applications therapeutiques
FR0100397 2001-01-12
FR0114688 2001-11-14
FR0114688 2001-11-14
PCT/FR2002/000092 WO2002055523A1 (fr) 2001-01-12 2002-01-11 Derives du mikanolide, leur preparation et leurs applications therapeutiques

Publications (2)

Publication Number Publication Date
DE60209698D1 true DE60209698D1 (de) 2006-05-04
DE60209698T2 DE60209698T2 (de) 2006-11-16

Family

ID=26212826

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60209698T Expired - Lifetime DE60209698T2 (de) 2001-01-12 2002-01-11 Mikanolid-derivate, ihre herstellung und ihr gebrauch für therapeutische anwendungen

Country Status (20)

Country Link
US (1) US6887869B2 (de)
EP (1) EP1353926B1 (de)
JP (1) JP4418627B2 (de)
KR (1) KR100859227B1 (de)
CN (1) CN1234711C (de)
AR (1) AR035681A1 (de)
AT (1) ATE319716T1 (de)
AU (1) AU2002229870B2 (de)
BR (1) BR0206311A (de)
CA (1) CA2433981A1 (de)
CZ (1) CZ20032167A3 (de)
DE (1) DE60209698T2 (de)
ES (1) ES2260417T3 (de)
MX (1) MXPA03006162A (de)
MY (1) MY130454A (de)
NZ (1) NZ526690A (de)
PL (1) PL365342A1 (de)
RU (1) RU2278121C2 (de)
TW (1) TWI293302B (de)
WO (1) WO2002055523A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2369083T3 (es) * 2003-07-11 2011-11-25 University Of Kentucky Research Foundation Uso de derivados de partenolida como agentes antileucémicos y citotóxicos.
US7678904B2 (en) 2003-07-11 2010-03-16 University Of Kentucky Use of parthenolide derivatives as antileukemic and cytotoxic agents
CN103004761B (zh) * 2012-12-27 2013-12-04 中山火炬职业技术学院 一种薇甘菊正丁醇提取物及其制备方法和用途
CN106719727A (zh) * 2016-12-13 2017-05-31 安徽东健化工科技有限公司 一种除虫剂
CN111484503B (zh) * 2020-01-10 2022-05-27 贵州省中国科学院天然产物化学重点实验室(贵州医科大学天然产物化学重点实验室) 一种薇甘菊内酯衍生物及其制备方法和应用
CN115918668B (zh) * 2022-12-13 2024-03-22 西南林业大学 倍半萜内酯作抗烟草花叶病毒药物的应用及其制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2801792B1 (fr) 1999-12-01 2003-04-18 Sod Conseils Rech Applic Un nouveau medicament, le dihydromikanolide, son obtention par extraction de la plante mikania micrantha et son utilisation comme agent anti-proliferatif

Also Published As

Publication number Publication date
TWI293302B (en) 2008-02-11
WO2002055523A1 (fr) 2002-07-18
RU2003124760A (ru) 2005-01-10
JP4418627B2 (ja) 2010-02-17
US6887869B2 (en) 2005-05-03
CN1234711C (zh) 2006-01-04
CA2433981A1 (fr) 2002-07-18
BR0206311A (pt) 2004-02-17
NZ526690A (en) 2005-02-25
US20040122084A1 (en) 2004-06-24
AR035681A1 (es) 2004-06-23
AU2002229870B2 (en) 2006-07-13
RU2278121C2 (ru) 2006-06-20
ATE319716T1 (de) 2006-03-15
MXPA03006162A (es) 2003-09-16
CN1484646A (zh) 2004-03-24
KR100859227B1 (ko) 2008-09-18
KR20030066806A (ko) 2003-08-09
EP1353926A1 (de) 2003-10-22
DE60209698T2 (de) 2006-11-16
CZ20032167A3 (en) 2004-05-12
MY130454A (en) 2007-06-29
JP2004520353A (ja) 2004-07-08
PL365342A1 (en) 2004-12-27
ES2260417T3 (es) 2006-11-01
EP1353926B1 (de) 2006-03-08

Similar Documents

Publication Publication Date Title
DE602004027932D1 (de) Benzimidazolderivate: herstellung und pharmazeutische anwendungen
DE602004022946D1 (de) 4-cyanopyrazol-3-carbonsäureamidderivate, herstellung und therapeutische anwendung davon
DE60203917D1 (de) Phenylsulfonyl-1,3-dihydro-2h-indol-2-on derivate, deren herstellung und deren therapeutische verwendung
DE60208622D1 (de) Siliciumoxidpulver und dessen Herstellung
ATE284886T1 (de) Benzimidazolderivate, ihre herstellung und therapeutische verwendung
IL193234A0 (en) Sulphonamide derivatives, the preparation thereof and the application of same as medicaments
NO20035157D0 (no) Lungeadministrering av kjemisk modifisert insulin
DE60106151D1 (de) Additionshärtbare Silikonelastomermischungen, ihre Herstellung und Verwendung
ATE296302T1 (de) 4-(1,3,4-thiadiazolyl-2-yl)-1,4-diazabizyklo- 3.2.2 nonanderivate, ihre herstellung und ihre therapeutische verwendung
ATE539062T1 (de) Bizyklishe verbindung, ihre herstellung und verwendung
DE602004020474D1 (de) Vegf-traps und deren therapeutische anwendungen
DE602005021501D1 (de) Sulfonamidderivate, ihre herstellung und ihre therapeutische anwendung
EE200300544A (et) 4-anilinokinoliin-3-karboksamiidid, nende kasutamine ning valmistamine
NO20041272L (no) Tetracycline derivatives and methods of use thereof
DE60105532D1 (de) Expandiertes Polytetrafluoroethylen für medizinische Anwendungen
EE200300311A (et) Ftalasinoon-piperidinoderivaadid, nende kasutamine ja ravim
ATE502035T1 (de) 2-amido-4-phenylthiazol-derivate, ihre herstellung und ihre therapeutische verwendung
DE60200427D1 (de) Vernetzbare Fluorelastomerzusammensetzungen, ihre Herstellung und Verwendung
DE602005019743D1 (de) Oxopiperidinderivate, ihre herstellung und therapeutische verwendung
ATE231869T1 (de) Pyridopyranoazepinderivate, ihre herstellung und therapeutische verwendung
DE60305037D1 (de) Piperazinylacylpiperidinderivate, deren herstellung und deren therapeutische anwendung
DE60208044D1 (de) Acylaminothiazolderivate, deren herstellung und deren therapeutische verwendung
DE60321372D1 (de) 3-phenylpyridoindolderivate, ihre herstellung und verwendung
DE602006015675D1 (de) 6-heteroarylpyridoindolon-derivate, ihre herstellung und ihre therapeutische anwendung
NO20041968L (no) Anvendelse av cystationin

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: IPSEN PHARMA S.A.S., BOULOGNE-BILLANCOURT, FR